baber/WOPTO huggingface dataset:
Patent EP-1008260-B1 (EP)
Inventor: BOYER FRANKLIN E
IPC: H04N5/44
Filed: 1998-08-19
Granted: 2002-05-15
Abstract: An Internet television program guide electronic-mail (e-mail) reminder system is provided. The system allows a user at a multimedia system to order and receive e-mail message reminders of scheduled television events over the Internet. The user can order e-mail reminders after selecting a program from the program listings or by supplying [a program title directly] specific user program preferences without having to consult the program listings. The user can specify when and how often the reminders will be generated and received. If desired, the user can view a list of all currently requested e-mail reminders. Entries can be added to the list or the user can cancel a previously ordered reminder. The user can order e-mail reminders for scheduled pay-per-view programs using the system. The user can also have reminder information periodically updated and available directly on the user's multimedia system.
Patent EP-1007584-B1 (EP)
Title: Procede de formation d'une dispersion de polytetrafluoroethylene
Inventor: BEATTY RICHARD P
IPC: C08J3/28
Filed: 1998-08-19
Granted: 2003-10-15
Abstract: Ce procédé de formation d'une dispersion de particules sèches de polytétrafluoroéthylène, dans un fluide organique porteur, comprend les étapes consistant: a) à fonctionnaliser la surface des particules de polytétrafluoroéthylène présentant un premier diamètre particulaire moyen inférieur à 1 micron, au moyen d'un faisceau d'électrons ou d'un rayonnement gamma d'au moins 4 Mrad, en présence d'oxygène atmosphérique et d'eau, ou à choisir des particules de polytétrafluoroéthylène, lesquelles possèdent un premier diamètre particulaire moyen inférieur à 1 micron et ont été soumises à un faisceau d'électrons ou à un rayonnement gamma d'au moins 4 Mrad, en présence d'oxygène atmosphérique et d'eau, afin de fonctionnaliser la surface de ces particules; b) à mélanger les particules soumises au rayonnement, avec le liquide et au moins un dispersant présent en quantité suffisant pour stabiliser la dispersion et former un mélange; c) à faire passer ce mélange, au moins une fois, à travers plusieurs buses situées dans une chambre d'interaction à jets de liquide, à une pression d'au moins 1000 psi, afin de désagglutiner les particules de polytétrafluoroéthylène.
Patent EP-1029838-B1 (EP)
Inventor: NOMURA MASAHIRO
IPC: C04B41/89
Filed: 1998-09-18
Granted: 2006-03-15
Abstract: L'invention concerne une structure comprenant une couche frittée céramique contenant du silicium, ainsi qu'une couche métallique contenant un métal actif en tant que couche de matière de brasage ou couche de métallisation assemblée ou déposée sur la surface de la couche frittée. Dans l'interface située entre la couche frittée et la couche métallique, on a formé une couche de réaction d'un composé comprenant des éléments constituant la couche frittée céramique et le métal actif. La couche de réaction est présente au-delà du pourtour extérieur de la couche métallique, et elle comprend notamment, lorsque la couche frittée céramique est une couche frittée de nitrure de silicium dont le métal actif est du titane, une première couche de réaction composée principalement de nitrure de titane et une seconde couche de réaction composée principalement de siliciure de titane. La première couche de réaction est présente au-delà du pourtour extérieur de la seconde couche de réaction. En fonction de la structure de brasage et de la structure métallisée, il est possible d'accroître les caractéristiques de la couche métallique contenant le métal actif, comme la résistance de l'assemblage, et de conserver une bonne reproductibilité.
Patent EP-1023063-B1 (EP)
Inventor: ARNOLD LEE D
IPC: C07D409/04
Filed: 1998-10-06
Granted: 2003-09-10
Abstract: Chemical compounds that are derivatives of indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole are inhibitors of tyrosine kinase activity. Several of the tyrosine kinases, whose activity is inhibited by these chemical compounds, are involved in hyperproliferative, angiogenic or in vascular hyperpermeability processes. Thus, these chemical compounds can ameliorate disease states where tumor formation, metastasis, angiogenesis, vascular hyperpermeability or endothelial cell proliferation is a factor.
Patent EP-1025140-B1 (EP)
Inventor: ZARKA PHILIPPE ETIENNE
IPC: C08L71/02
Filed: 1998-10-21
Granted: 2002-02-06
Abstract: There is described a polyol formulation comprising 20 to 65 wt.% of polyol of a first type having a number average molecular weight of greater than 800, a hydroxyl value of less than 200 mg KOH/g and an ethylene oxide content of less than 75 wt.% and, forming a miscible mixture therewith, 35 to 80 wt.% of polyol of a second type having a number average molecular weight of less than 1000, a hydroxyl value of greater than 300 mg KOH/g and an amine content (expressed in terms of the percentage of N) of at least 0.2 wt.%. The formulation is especially useful for preparing a semi-flexible polyurethane foam having a softening temperature of 120  DEG C or more which may be used in insulating pipes.
Patent EP-1044026-B1 (EP)
Inventor: ROSE EDWARD V
IPC: A23L3/28
Filed: 1998-12-17
Granted: 2003-11-05
Abstract: A method and apparatus for sterilizing organic or inorganic matter through simultaneous exposure to ultraviolet light energy and ultrasonic wave energy in a non-aqueous environment such as air. The method is suitable for use in a chamber or in a mass production assembly line setting. Purification of air is similarly accomplished using simultaneous exposure to ultraviolet light and ultrasonic energy waves.
Patent EP-1044377-B1 (EP)
Inventor: LUDWIG HANNS
IPC: G01N33/569
Filed: 1998-12-24
Granted: 2007-07-18
Abstract: The invention allows, for the first time, to (almost) perfectly detect the various phases of a BDV infection in all species by combining a newly discovered test parameter, the circulating immune complexes (CICs) in the blood plasma, with already known parameters, antigen (AG) in white blood cells and antibodies (AK) in the plasma. All three parameters can be determined from a single blood sample. The detection of BDV-specific CICs described for the first time by the invention as the only infection markers with long-time persistence allows both the detection of healthy carriers (latent infections) and the evaluation of the development of the infection and of therapy results in the case of diseased individuals.
Patent EP-1021957-B1 (EP)
Inventor: NAVARINI LUCIANO
IPC: A23F5/24
Filed: 1999-01-21
Granted: 2004-08-04
Abstract: A new heavily foaming coffee fraction as well as a process for its manufacture is described. The heavily foaming coffee fraction of this invention is characterized by the following bands in the FT-IR-spectrum: 3400 cm<-1>, 2900 cm<-1>, 1655 cm<-1>, 1524 cm<-1>, 1000-1150 cm<-1>, 894 cm<-1> and 876 cm<-1>. The production process for the above-mentioned coffee fraction comprises the following steps:   (1) defatting of ground, roasted coffee with an organic solvent and extracting of the defatted ground, dark roasted coffee with hot water,   (2) filtrating the extract obtained from step (1), (3) adding a precipitation agent to the extract obtained from step (2) and centrifugation of the thus obtained precipitate, (4) dissolving the precipitate obtained from step (3) in water or an aqueous alcohol,   (5) dialysing the solution obtained in step (4) against water,   (6) filtrating the non-dialysable solution and   (7) freeze-drying the filtrate obtained in step (6).   The addition of the foaming coffee fractions of the present invention to commercial coffee powders results in improved volume, persistency and consistency properties.
Patent EP-0949308-B1 (EP)
Inventor: ROESLER RICHARD R
IPC: C08G18/70
Filed: 1999-03-29
Granted: 2005-04-27
Abstract: The present invention relates to compounds which are substantially free from isocyanate groups, have an alkoxysilane group content (calculated as Si, MW 28) of 1 to 6% by weight, based on the weight of the compounds, and containing sufficient chemically incorporated hydrophilic groups to form a stable dispersion with water, wherein the alkoxysilane groups are incorporated as the reaction products of   a) a polyisocyanate component having a minimum average functionality of 2.4 and containing at least 50 % by weight of polyisocyanate adducts and b) compounds containing secondary amino groups and alkoxysilane groups.   The present invention also relates to the use of these compounds for the preparation of coatings, sealants and adhesives.
Patent EP-0981986-B1 (EP)
Inventor: WILLPUETZ MICHAEL
IPC: A47G25/48
Filed: 1999-08-18
Granted: 2003-12-17
Abstract: The injection moulded clothes hanger has an elastic tongue-shaped part (13) positioned above both outer ends of the arms (22). A piece of underwear especially men's shorts (22) is pulled over the ends of the arms (11) with the waist part (22) pushed into two gaps (19,20) and held in place by the tongue-shaped element (13) on top and an elastic fixing hook (12) from below.
Patent EP-1000728-B1 (EP)
Inventor: LACOUR JEAN-CHARLES
IPC: B29D30/06
Filed: 1999-11-08
Granted: 2002-07-03
Abstract: A support having a reinforced base extending between inner and outer cylindrical surfaces at least one of which has hollows is manufactured in a closed mold. The annular mold has radially separated parts forming the outer cylindrical surface, a core for forming the inner surface and shell(s) with fingers for forming the hollows. A preformed reinforced ring is placed on a selected core in the mold. Elastic material is injected into the mold under pressure and the shell(s) moved axially. An Independent claim is included for the following: (a) A mold as above. Preferred Features: The ring has circumferential reinforcing threads. The ring is placed under tension during molding.
Patent EP-1094338-B1 (EP)
Inventor: VAN RIEL PAUL
IPC: G01V1/30
Filed: 1999-10-22
Granted: 2006-08-23
Abstract: The invention relates to a method for determining from measured reflection data on a plurality of trace positions one or more subsurface parameters, said method comprising the steps of: a) preprocessing the measured reflection data into a plurality of partial or full stacks; b) specifying one or more initial subsurface parameters defining an initial subsurface model; c) specifying a wavelet or wavelet field for each of the partial or full stacks of the preprocessed measured reflection data; d) calculating synthetic reflection data based on the specified wavelets and the initial subsurface parameters; e) optimizing an objective function, comprising the weighted difference between preprocessed measured reflection data and synthetic reflection data, for a plurality of trace positions simultaneously; f) outputting the optimized one or more subsurface parameters.
Patent EP-0953346-B1 (EP)
Inventor: BRETON LIONEL
IPC: A61Q19/00
Filed: 1999-04-08
Granted: 2003-11-26
Abstract: The hydroxystilbenes are effective collagen-synthesizing, and/or fibroblast-proliferating, and/or protease expression-inhibiting, and/or skin aging-combating, and/or flaccid/wrinkled skin-treating, and/or skin-smoothing/firming, and/or menopausal cutaneous effect-treating, and/or menopausal collagen/fibroblast effects-treating active agents, for topical application onto the skin and/or mucous membranes of a human subject in need of such treatment(s).
Patent EP-1004307-B1 (EP)
Inventor: UENO RYUJI
IPC: A61K31/517
Filed: 1999-01-29
Granted: 2002-09-04
Abstract: La composition ophtalmique de l'invention est utilisée dans le traitement des lésions cornéennes d'origine diabétique et/ou des lésions qui perturbent la sensibilité cornéenne. Cette composition comprend, comme ingrédient actif, un composé représenté par la formule générale (I) dans laquelle A et B représentent indépendamment alkylène inférieur; X, Y et Z représentent indépendamment halogène, ou un sel pharmaceutiquement acceptable. Cette composition ophtalmique est également utilisée dans le traitement des lésions cornéennes d'origine non diabétique, du syndrome des yeux secs, et/ou de la diminution de la production lacrymale, et comprend, comme ingrédient actif, un inhibiteur d'aldose réductase. Les compositions ophtalmiques de cette invention sont efficaces dans le traitement d'au moins une maladie sélectionnée parmi les lésions cornéennes, les lésions qui perturbent la sensibilité cornéenne, le syndrome des yeux secs et la diminution de la production lacrymale.
Patent EP-1068106-B1 (EP)
Inventor: JOST STEFAN
IPC: B60R21/26
Filed: 1999-01-21
Granted: 2005-09-21
Abstract: L'invention concerne une garniture de plafond de véhicule automobile doté d'au moins un module de sac à air comprimé placé dans la zone du plafond dudit véhicule. Le module de sac à air comprimé est constitué d'un sac à air comprimé (2) et d'un conduit pour le gaz (16), le tout étant intégré dans la garniture du plafond, de sorte que le module de sac à air comprimé et que la garniture de plafond forment un tout.
Patent EP-1068536-B1 (EP)
Inventor: EXNER THOMAS
IPC: G01N33/86
Filed: 1999-02-01
Granted: 2004-04-28
Abstract: A method of determining the coagulation potential of a plasma sample be pre-incubating the plasma sample with a reagent such that endogenous protein C in the plasma is at least partially converted into activated protein C by the reagent, adding factor Xa which is progressively inactivated by antithrombin III/heparin cofactor 2 during the preincubation, adding an exogenous reagent which activates factor X to Xa or prothrombin to thrombin in a factor V-dependent manner, monitoring a reaction indicative of the rate of coagulation of the plasma sample, comparing that rate of coagulation control, or the equivalent rate determined for an individual without impaired coagulation control, or the equivalent rate determined for the plasma sample in the absence of protein C activator, and determining the coagulation potential of the plasma sample from one or other of the compairsons.
Patent EP-0985084-B1 (EP)
Inventor: KAWAMOTO SHIRO
IPC: F02B25/02
Filed: 1999-03-05
Granted: 2005-05-18
Abstract: A portable, operator-carried power tool having an implement supported on frame, and a lightweight, four-stroke, engine drivably connected to the implement. The engine has a crankshaft situated in a crankshaft housing and a cylinder block secured to the housing, the crankshaft being provided with a crankcase ventilation passage extending between the crankcase and an outlet end in communication with an air/fuel induction passage. A passage establishes communication between the interior of the crankcase and the valve chamber through a cam and cam gear region of the cylinder block. An oil mist generator is connected drivably to the crankshaft for agitating liquid oil in the crankcase to establish a lubricating oil mist. The crankcase, cam region and valve chamber form a containment whereby oil mist is distributed throughout the engine during operation regardless of angular orientation.
Patent EP-1119359-B1 (EP)
Inventor: BUNNELL CHARLES ARTHUR
IPC: A61K31/55
Filed: 1999-03-24
Granted: 2004-05-26
Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
Patent EP-1009710-B1 (EP)
Inventor: PICKEL HERBERT
IPC: B67C3/24
Filed: 1999-03-30
Granted: 2001-10-31
Abstract: A device for introducing containers into a treatment space and for removing the containers from said treatment space having at least one rotatable sluice wheel provided on the periphery with sluice chambers that are open toward the outside, the sluice wheel being provided with grippers that can be operated directly by the containers or indirectly by a control device, for securing the containers temporarily in the sluice chambers, preferably by suspending the containers without allowing them to come in contact with the chamber walls and without providing any bottom support. A trouble-free conveyance of the containers with a very high output is possible without damaging the containers, even when the containers are very susceptible to tilting.
Patent EP-1076644-B1 (EP)
Inventor: DAX SCOTT L
IPC: C07D333/34
Filed: 1999-04-12
Granted: 2004-06-23
Abstract: beta -Aminotetralin derivatives of the formula: which are ligands for the neuropeptide Y Y5 (NPY5) receptor, methods of preparation and pharmaceutical compositions containing a  beta -aminotetralin derivative as the active ingredient are described. The  beta -aminotetralins are useful in the treatment of disorders and diseases associated with NPY receptor subtype Y5.
Patent EP-1006386-B1 (EP)
Inventor: UOMORI KENYA
IPC: G01B11/00
Filed: 1999-05-24
Granted: 2011-05-04
Abstract: On décrit un télémètre utilisé pour mesurer la distance s'étendant jusqu'à un objet. Pour mesurer cette distance le télémètre (a) envoie des faisceaux de lumière ayant des diagrammes de rayonnement dont les intensités lumineuses sont différentes de manière tridimensionnelle dans un mode de répartition temporelle en direction de l'objet à partir d'une source de lumière; (b) reçoit la lumière réfléchie par l'objet pour obtenir une image de l'objet; et (c) utilise l'intensité lumineuse de l'image de l'objet. Dans ce dispositif les relations existants entre les angles des faisceaux de lumière projetés à partir de la source de lumière au niveau des surfaces comprenant le centre de la source de lumière et le centre de la lentille et les rapports entre les intensités lumineuses sont déterminés, les intensités lumineuses des pixels de l'appareil photographique sont mesurées lorsque la distance est effectivement mesurée, l'angle correspondant à l'intensité lumineuse mesurée d'un pixel prédéterminé étant déterminé sur la base des intensités lumineuses mesurées et des relations existant entre les angles et les rapports entre les intensités lumineuses au niveau d'une surface prédéterminée correspondant aux coordonnées d'un pixel mesuré; et la distance jusqu'à l'objet est elle-même calculée sur la base des intensités lumineuses mesurées, des angles déterminés, et des informations relatives aux coordonnées bidimensionnelles de la position d'un pixel prédéterminé sur l'image.
Patent EP-1458083-B1 (EP)
Inventor: BORREGO BEL CARLES
IPC: B60L11/18
Filed: 1999-06-09
Granted: 2012-04-04
Abstract: L'invention trouve une application dans des véhicules à deux réseaux électriques et à charges correspondantes en deux niveaux de tension différenciés, comprenant deux batteries à un premier et à un second niveau de tension. Un convertisseur de tension bidirectionnel est associé aux deux réseaux et ses deux étapes d'entrée et sortie sont isolées galvaniquement et dotées chacune d'un commutateur. Les batteries sont connectées au niveau de l'entrée et de la sortie à des premier et second niveaux de tension de telle sorte que le convertisseur bidirectionnel offre un premier mode d'abaissement de tension et un second mode d'élévation de tension. Les composants passifs, à savoir les composants magnétiques et capacitifs, desdites étapes sont sélectionnés pour assurer un comportement transitoire identique pour les deux modes lorsqu'une perturbation se produit dans le système de régulation, soit au niveau de la charge soit au niveau de la tension d'entrée.
Patent EP-1028535-B1 (EP)
Inventor: TSUJI TOSHIAKI
IPC: H04B1/16
Filed: 1999-06-09
Granted: 2005-06-08
Abstract: When an STB is powered off when it is not used (when it is changed to the sleep mode) for the purpose of power-saving, a difference in a subtracter 11 immediately therebefore is held by a control circuit 12 and an oscillation circuit 15 is controlled on the basis of the difference, thereby performing reserved processing at a correct time even when the STB is in the sleep mode. <IMAGE>
Patent EP-1097712-B1 (EP)
Inventor: MUTA KAZUNORI
IPC: A61K47/18
Filed: 1999-07-07
Granted: 2003-10-01
Abstract: A steroid-containing gel patch containing a steroid as an effective ingredient at 0.005 to 0.05 % by weight, crotamiton as a stabilizer at 15 % by weight or less and a surfactant in a base, where the amount of the crotamiton blended being 200 to 3000-fold the weight of the steroid blended and the amount of the surfactant blended being 1/20 to 1/5-fold the weight of the crotamiton blended.
Patent EP-1198973-B1 (EP)
Inventor: BAECHLER HERBERT
IPC: H04R29/00
Filed: 1999-07-29
Granted: 2003-06-18
Abstract: L'invention concerne une unité d'adaptation pour appareil de correction auditive, caractérisée en ce qu'une première unité d'interface pour l'émission de signaux à un appareil de correction auditive (7) et une deuxième unité d'interface pour la réception de signaux de réaction audio-stimulants individuels sont formées par une seule et même unité d'interface (13).
Patent EP-1098776-B1 (EP)
Inventor: CHAPMAN DAVID MONROE
IPC: C08L29/04
Filed: 1999-07-08
Granted: 2004-03-17
Abstract: The coating composition comprises inorganic oxide, e.g., silica, in combination with a binder system comprising a mixture of a water soluble polymer and a non-ionic latex polymer. The composition may contain optional dye mordant (e.g., cationic polymer). It is found that the combinations of these components result in relatively high solids formulations (e.g., greater than 20 % by weight) with relatively low viscosity (less than 5000 centipoise), do not exhibit coating dusting, and give exceptional ink-jet printability. These formulations are especially suitable for preparing on-line formulations because they can be formulated to have a viscosity less than 2000 centipoise. Preferable embodiments for on-line coatings have a viscosity less than 1000 centipoise.
Patent EP-1091833-B1 (EP)
Inventor: COLLINS JOHN WILLIAM
IPC: B24B23/04
Filed: 1999-04-01
Granted: 2003-11-26
Abstract: A sanding apparatus includes a plurality of sheet elements with exposed, abrasive edges. These sheet elements are biased outwardly with respect to the housing by a compressible foam block. The exposed abrasive edges together define a conformable abrasive surface for sanding moldings and the like. The plurality of sheet elements may include a replaceable cassette.
Patent EP-1115708-B1 (EP)
Inventor: JAROCH STEFAN
IPC: C07D221/22
Filed: 1999-09-20
Granted: 2004-04-14
Abstract: Composés de formule I, leurs formes tautomères et isomères et leurs sels, ainsi que procédés de préparation et d'utilisation desdits composés dans des produits pharmaceutiques.
Patent EP-1126878-B1 (EP)
Inventor: PERETZ TUVIA
IPC: A61K38/00
Filed: 1999-10-28
Granted: 2009-09-16
Abstract: A method of treating a condition associated with heparanase expression by administering a heparanase activity neutralizing monoclonal anti-heparanase antibody, the monoclonal anti-heparanase antibody being for neutralizing heparanase catalytic activity.
Patent EP-1137359-B1 (EP)
Inventor: ZAMZOW MANFRED
IPC: A47L1/00
Filed: 1999-11-16
Granted: 2003-09-24
Abstract: The invention relates to parts of an armature that in terms of appearance and haptics correspond to granite decor kitchen sink units and/or work surfaces made of hardenable casting materials and produced using hardenable casting materials. Said casting materials are 58-85 % comprised of a mineral, particle-shaped filler with particle sizes ranging from 0.1-2 mm, in addition to containing a rheologically active additive that is selected in such a way that a reduction in the amount of fillers during the casting and hardening process can be avoided to a substantial extent. The viscosity of the casting materials containing said additive is however 6.3 Pas or lower.